Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: oral insulin - Aphios Corporation

Drug Profile

Research programme: oral insulin - Aphios Corporation

Alternative Names: APH-0907; oral insulin - Aphios

Latest Information Update: 25 Nov 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Aphios Corporation
  • Class Insulins; Pancreatic hormones
  • Mechanism of Action Ornithine decarboxylase stimulants; Pancreatic hormone receptor agonists; Phosphokinase stimulants; Protein tyrosine kinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Diabetes mellitus

Most Recent Events

  • 25 Nov 2021 Preclinical trials in Diabetes mellitus in USA (PO) prior to November 2021 (Aphios Corporation pipeline, November 2021)
  • 20 Oct 2014 Research programme: oral insulin - Aphios Corporation is available for licensing as of 20 Oct 2014. http://www.aphios.com/products/therapeutic-product-pipeline/diabetes/aph-0907.html
  • 17 Dec 2012 Early research in Diabetes mellitus in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top